FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine and concerns a new sustained release cilostasol pharmaceutical composition for preventing intermittent claudication and secondary strokes.
EFFECT: sustained release cilostasol tablets are disclosed.
6 cl, 5 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES | 2004 |
|
RU2380093C2 |
METHOD OF DIABETES TREATMENT | 2007 |
|
RU2442585C2 |
PHARMACEUTICAL COMBINATION CONTAINING VINPOCETINE AND BETAHISTINE FOR TREATING CEREBRAL CIRCULATORY DEPRESSION | 2008 |
|
RU2386439C2 |
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT | 2006 |
|
RU2442574C2 |
ORAL PREPARATION WITH SUSTAINED RELEASE | 2015 |
|
RU2696870C2 |
COMPOSITION FOR TREATING DISTURBED INNERVATION (VERSIONS) | 2013 |
|
RU2536269C1 |
CAPSULE AND DRUG PREPARATION FOR PREVENTING CARDIOVASCULAR DISEASES | 2009 |
|
RU2477123C2 |
PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE | 2005 |
|
RU2382648C2 |
MODIFIED RELEASE PHARMACEUTICAL COMPOSITION BASED ON CLOZAPINE POLYMORPHS | 2024 |
|
RU2836778C1 |
MATRIX TABLET WITH BASIS FOR TRIMETAZIDINE DIHYDROCHLORIDE RELEASE, WAY OF ITS RECEPTION AND WAY OF TREATMENT | 2007 |
|
RU2362548C1 |
Authors
Dates
2019-04-24—Published
2018-05-11—Filed